Fortem Financial Group, LLC Bristol Myers Squibb CO Transaction History

Fortem Financial Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$40.25 - $52.99 $19,722 - $25,965	-490 Reduced 3.55%	13,313 $552,000
Q1 2024 May 01, 2024	BUY	$47.98 - $54.4 $94,328 - $106,950	1,966 Added 16.61%	13,803 $748,000
Q4 2023 Jan 25, 2024	SELL	$48.48 - $57.85 $56,867 - $67,858	-1,173 Reduced 9.02%	11,837 $607,000
Q3 2023 Oct 10, 2023	SELL	$57.89 - $64.73 $171,875 - $192,183	-2,969 Reduced 18.58%	13,010 $755,000
Q2 2023 Jul 18, 2023	BUY	$63.71 - $70.74 $88,684 - $98,470	1,392 Added 9.54%	15,979 $1.02 Million
Q1 2023 Apr 21, 2023	SELL	$65.71 - $74.53 $239,644 - $271,810	-3,647 Reduced 20.0%	14,587 $1.01 Million
Q4 2022 Jan 17, 2023	SELL	$68.48 - $81.09 $2,807 - $3,324	-41 Reduced 0.22%	18,234 $0
Q3 2022 Nov 01, 2022	BUY	$0.13 - $76.84 $2,375 - $1.4 Million	18,275 New	18,275 $1.3 Million
Q1 2021 Apr 20, 2021	SELL	$59.34 - $66.74 $5,934 - $6,673	-100 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$57.74 - $65.43 $5,774 - $6,543	100 New	100 $6,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Fortem Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Fortem Financial Group, LLC with notifications on news.